Skip to main content
Sister Publication Links
  • ModernHealthcare.com
Subscribe
  • My Account
  • Login
  • Register
  • Consumer Centric
  • Provider/Payer Centric
  • Funding/M&A
  • Policy
  • Data
  • Opinion
  • MORE+
    • Webinars
    • Advertise
MENU
Breadcrumb
  1. Home
  2. Operations
June 21, 2022 09:14 AM

Truveta partners with Pfizer to monitor COVID-19 therapies, treatments

Brock E.W. Turner
  • Tweet
  • Share
  • Share
  • Email
  • More
    Reprints Print
    Pfizer Vax vials
    Wikimedia Commons

    Truveta, a data platform company backed by some of the country’s largest health systems, is partnering with big pharma company Pfizer to monitor the safety of its COVID-19 vaccines and therapies.

    Altogether, the partnership will give Pfizer access to data from Truveta's 20 health system members across 42 states. These health systems represent more than 16% of U.S. patient care.

    Truveta said the partnership will allow Pfizer to evaluate and identify trends and treatments in real-time using de-identified data from 50 million people. The data doesn't just use clinical information from the electronic health record but socio-economic data and daily mortality data as well. The company's CEO Terry Myerson said he’s optimistic this deal can bolster trust and begin to combat vaccine hesitancy.

    “I think at some level, that's why it's so important for us to have such a large data set, because even America is so diverse,” Myerson said. “I think that's a high bar for us to hit and we aspire to hit it. We aspire to be that trusted data set in the US that's representative.”

    Myerson declined to share specifics on how health systems are compensated through this deal, but said it is relatively proportional to the overall number of patients. The company compensates its partners for anonymized patient data submitted by providers.

    In November 2021, Truveta secured nearly $200 million in funding and launched its de-identified health data platform. It also added Ochsner Health, Saint Luke’s Health System and UnityPoint Health as members. 

     

     

    Letter
    to the
    Editor

    Send us a letter

    Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it online.

    Recommended for You
    COVID-19 VAX
    One insurer’s challenge to increase vaccine access in underserved communities
    RiteAid
    Rite Aid-Homeward is potential roadmap for rural telehealth adoption
    Sponsored Content
    Get Newsletters

    Newsletters for providers, payers, investors and innovators across the digital health ecosystem. Sign up to get breaking digital health news including digital health deals, M&A, finance, IPOs. as they happen, right to your inbox.

    Buy Q1 Report Today
    Quarterly Report Cover Image

    The Digital Health Funding and M&A Q1 report delivers the most comprehensive insight and data around the financial health of the sector.

    Purchase Today
    Connect with Us
    • LinkedIn
    • Twitter
    • Facebook
    • RSS

    Digital Health Business & Technology delivers news, data, insights and analysis covering the entire digital healthcare ecosystem.

    Logo
    Contact Us

    (877) 812-1581

    Email us

     

    Editorial Dept
    • Submission Guidelines
    • Code of Ethics
    Resources
    • About Us
    • Contact Us
    • Staff
    • Advertise with Us
    • Ad Choices Ad Choices
    • Sitemap
    Legal
    • Terms and Conditions
    • Privacy Policy
    • Privacy Request
    Digital Health Business & Technology
    Copyright © 1996-2022. Crain Communications, Inc. All Rights Reserved.
    • Consumer Centric
    • Provider/Payer Centric
    • Funding/M&A
    • Policy
    • Data
    • Opinion
    • MORE+
      • Webinars
      • Advertise